Petrus Resources Announces Monthly Activity Update

March 27, 2025

CALGARY, Alberta, March 27, 2025 (GLOBE NEWSWIRE) — Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to announce the most recent version of the Company’s monthly activity update can be found on the Company’s website at https://www.petrusresources.com/monthlyupdates.

ABOUT PETRUS
Petrus is a public Canadian oil and gas company focused on property exploitation, strategic acquisitions and risk-managed exploration in Alberta.

FOR FURTHER INFORMATION PLEASE CONTACT:
Ken Gray
President and Chief Executive Officer
T: 403-930-0889
E: [email protected]

Hot this week

Topics

Popular Categories

News RoomFeatured CompaniesVideos

Inventronics Announces 2024 Year End Financial Results

Vertical Aerospace Unfairly Undervalued, Says Bullish Analyst

Petrus Resources Announces Monthly Activity Update

First Three Children to Commence Treatment With Ryoncil®

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study

FirstFarms A/S: Confirmed case of Foot and Mouth Disease on farm in Slovakia

Mandatory Notification of Trade

Possible symptoms of Foot and Mouth Disease in one animal in FirstFarms’ herd in Slovakia

Topics

First Three Children to Commence Treatment With Ryoncil®

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study

FirstFarms A/S: Confirmed case of Foot and Mouth Disease on farm in Slovakia

Mandatory Notification of Trade

Possible symptoms of Foot and Mouth Disease in one animal in FirstFarms’ herd in Slovakia

BYD Energy Storage Launches Chess Plus for C&I Energy Storage in China

EHang’s EH216-S eVTOL Operators Obtain Air Operator Certificates

Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress

Related Articles

First Three Children to Commence Treatment With Ryoncil®

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study

FirstFarms A/S: Confirmed case of Foot and Mouth Disease on farm in Slovakia

Mandatory Notification of Trade

Possible symptoms of Foot and Mouth Disease in one animal in FirstFarms’ herd in Slovakia

Company

Headlines

First Three Children to Commence Treatment With Ryoncil®

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study

FirstFarms A/S: Confirmed case of Foot and Mouth Disease on farm in Slovakia

Mandatory Notification of Trade

Newsletter